• Explore /
  • Poster
  • / NSABP B-43: A phase III clinical trial to compare trastuzumab (T) given concurrently with radiation therapy (RT) to RT alone for women with HER2+ DCIS resected by lumpectomy (Lx).

NSABP B-43: A phase III clinical trial to compare trastuzumab (T) given concurrently with radiation therapy (RT) to RT alone for women with HER2+ DCIS resected by lumpectomy (Lx).

Abstract Poster

Authors

null

Melody A. Cobleigh

Rush University Medical Center, Chicago, IL

Melody A. Cobleigh , Stewart J. Anderson , Thomas B. Julian , Kalliopi P. Siziopikou , Douglas W. Arthur , Rachel Rabinovitch , Ping Zheng , Eleftherios P. Mamounas , Norman Wolmark

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2013 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Breast Cancer - HER2/ER

Track

Breast Cancer

Sub Track

HER2+

Clinical Trial Registration Number

NCT00769379

Citation

J Clin Oncol 31, 2013 (suppl; abstr TPS666)

DOI

10.1200/jco.2013.31.15_suppl.tps666

Abstract #

TPS666

Poster Bd #

17B

Abstract Disclosures

Similar Posters

First Author: Melody A. Cobleigh

First Author: Tanios S. Bekaii-Saab

First Author: Maria Vittoria Dieci

First Author: Sayeh Moazami Lavasani